Migraine Disease Clinical Trial
Official title:
The Migraine and Pain Study GeneBank at Scripps Clinic Registry (MAPS)
The objective of this study is to obtain blood or saliva samples to define genes for migraine and pain diseases.
It is estimated that over one-third of the world's population suffers from persistent or recurrent pain. Migraine is highly heritable and the majority of juveniles who suffer from the disorder have a mother or father who also have the disease. The blood or saliva samples will go through DNA analysis and be sequenced for candidate genes or subjected to whole-genome sequencing. By creating a MAPS GeneBank from these patients' blood/saliva donations we will ultimately be able to define genes for migraine and pain diseases. ;
Observational Model: Family-Based